Literature DB >> 12391229

Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-6I recognize two potential ligands expressed by B lymphocytes.

David L Pflugh1, Stephen E Maher, Alfred L M Bothwell.   

Abstract

Most hemopoietic cells express one or more members of the Ly-6 supergene family of small glycosylphosphatidylinositol-linked proteins. Although levels of Ly-6 proteins vary with stages of differentiation and activation, their function largely remains unknown. To ascertain whether ligands for Ly-6 proteins exist, chimeric proteins were constructed in which Ly-6E, Ly-6C, and Ly-6I were fused to the murine IgM heavy chain. These chimeras specifically stained both developing and mature B lymphocytes, as assessed by flow cytometry. Analysis of variants of the CH27 B cell lymphoma revealed that Ly-6A/E and Ly-6I recognized different molecules. CH27 cells with low levels of Ly-6A/E ligand activity also lost expression of CD22, and cells transfected with CD22 gained the ability to bind the Ly-6A/E chimera and, to a lesser extent, the Ly-6C and Ly-6I chimeric proteins. As many mature B cells coexpress Ly-6A/E and CD22, the function of Ly-6 molecules may be to associate with other membrane proteins, possibly concentrating these ligands in lipid rafts, rather than acting directly as cell:cell adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391229     DOI: 10.4049/jimmunol.169.9.5130

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Urine proteomics for profiling of human disease using high accuracy mass spectrometry.

Authors:  Alex Kentsis; Flavio Monigatti; Kevin Dorff; Fabien Campagne; Richard Bachur; Hanno Steen
Journal:  Proteomics Clin Appl       Date:  2009-09-01       Impact factor: 3.494

2.  Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata.

Authors:  Filip K Swirski; Peter Libby; Elena Aikawa; Pilar Alcaide; F William Luscinskas; Ralph Weissleder; Mikael J Pittet
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Markers of nonselective and specific NK cell activation.

Authors:  Leslie A Fogel; Michel M Sun; Theresa L Geurs; Leonidas N Carayannopoulos; Anthony R French
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

4.  The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier.

Authors:  Juliette Hordeaux; Yuan Yuan; Peter M Clark; Qiang Wang; R Alexander Martino; Joshua J Sims; Peter Bell; Angela Raymond; William L Stanford; James M Wilson
Journal:  Mol Ther       Date:  2019-02-20       Impact factor: 11.454

Review 5.  CD22 and Siglec-G in B cell function and tolerance.

Authors:  Jonathan C Poe; Thomas F Tedder
Journal:  Trends Immunol       Date:  2012-06-05       Impact factor: 16.687

6.  Sca-1 expression is required for efficient remodeling of the extracellular matrix during skeletal muscle regeneration.

Authors:  Kimberly A Kafadar; Lin Yi; Yusra Ahmad; Leslie So; Fabio Rossi; Grace K Pavlath
Journal:  Dev Biol       Date:  2008-11-06       Impact factor: 3.582

7.  Shifts in bone marrow cell phenotypes caused by spaceflight.

Authors:  M Teresa Ortega; Michael J Pecaut; Daila S Gridley; Louis S Stodieck; Virginia Ferguson; Stephen K Chapes
Journal:  J Appl Physiol (1985)       Date:  2008-12-04

8.  Mice deficient in stem cell antigen-1 (Sca1, Ly-6A/E) develop normal primary and memory CD4+ and CD8+ T-cell responses to virus infection.

Authors:  Jason K Whitmire; Boreth Eam; J Lindsay Whitton
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

9.  Activation and Costimulation of Intestinal T Cells: Independent and Collaborative Involvement of CD43, OX40, and Ly-6C.

Authors:  Dina Montufar-Solis; John R Klein
Journal:  Curr Immunol Rev       Date:  2005-01

Review 10.  CD22: an inhibitory enigma.

Authors:  Jennifer A Walker; Kenneth G C Smith
Journal:  Immunology       Date:  2007-12-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.